Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sangamo Biosciences Company Profile (NASDAQ:SGMO)

Consensus Ratings for Sangamo Biosciences (NASDAQ:SGMO) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $23.25 (58.16% upside)

Analysts' Ratings History for Sangamo Biosciences (NASDAQ:SGMO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/23/2015WedbushSet Price TargetBuy$30.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2015BMO Capital MarketsInitiated CoverageOutperform$19.00ViewTweet This Rating  Share This Rating on StockTwits
3/1/2015WedbushReiterated RatingOutperform$30.00ViewTweet This Rating  Share This Rating on StockTwits
2/11/2015WedbushReiterated RatingOutperform$30.00ViewTweet This Rating  Share This Rating on StockTwits
2/4/2015WedbushInitiated CoverageBuy$29.00ViewTweet This Rating  Share This Rating on StockTwits
1/27/2015WedbushInitiated CoverageBuy$29.00ViewTweet This Rating  Share This Rating on StockTwits
1/12/2015WedbushReiterated RatingOutperform$29.00ViewTweet This Rating  Share This Rating on StockTwits
10/28/2014TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
9/23/2014Jefferies GroupInitiated CoverageBuy$22.00ViewTweet This Rating  Share This Rating on StockTwits
9/10/2014WedbushBoost Price Target$27.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2014JPMorgan Chase & Co.Initiated CoverageOverweight$22.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2014JMP SecuritiesBoost Price TargetOutperform$22.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2014WedbushBoost Price Target$22.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013WedbushBoost Price TargetOutperform$13.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2013Lazard Capital MarketsBoost Price TargetBuy$16.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
6/17/2013Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
5/3/2013BioLogic Equity ResearchInitiated CoverageSellViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/24/2013 forward)